<VariationArchive VariationID="242535" VariationName="NM_000492.3(CFTR):c.1210-12T[5]" VariationType="Deletion" Accession="VCV000242535" Version="58" RecordType="classified" NumberOfSubmissions="24" NumberOfSubmitters="21" DateLastUpdated="2024-07-29" DateCreated="2016-05-29" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="205614" VariationID="242535">
      <GeneList>
        <Gene Symbol="CFTR" FullName="CF transmembrane conductance regulator" GeneID="1080" HGNC_ID="HGNC:1884" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="117480025" stop="117668665" display_start="117480025" display_stop="117668665" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="117120016" stop="117308718" display_start="117120016" display_stop="117308718" Strand="+" />
          </Location>
          <OMIM>602421</OMIM>
        </Gene>
        <Gene Symbol="CFTR-AS1" FullName="CFTR antisense RNA 1" GeneID="111082987" HGNC_ID="HGNC:40144" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="117542521" stop="117564676" display_start="117542521" display_stop="117564676" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000492.3(CFTR):c.1210-12T[5]</Name>
      <CanonicalSPDI>NC_000007.14:117548628:TTTTTTT:TTTTT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q31.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="117548629" stop="117548630" display_start="117548629" display_stop="117548630" variantLength="2" positionVCF="117548628" referenceAlleleVCF="GTT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="117188683" stop="117188683" display_start="117188683" display_stop="117188683" positionVCF="117188682" referenceAlleleVCF="GTT" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>5T/7T/9T</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.117548629T[5]" Assembly="GRCh38">
            <Expression>NC_000007.14:g.117548629T[5]</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.117188683T[5]" Assembly="GRCh37">
            <Expression>NC_000007.13:g.117188683T[5]</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016465.4" sequenceAccession="NG_016465" sequenceVersion="4" change="g.87846T[5]">
            <Expression>NG_016465.4:g.87846T[5]</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000492.3" sequenceAccession="NM_000492" sequenceVersion="3" change="c.1210-12[5]">
            <Expression>NM_000492.3:c.1210-12[5]</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000492.3" sequenceAccession="NM_000492" sequenceVersion="3" change="c.1210-7_1210-6delTT">
            <Expression>NM_000492.3:c.1210-7_1210-6delTT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000492.3" sequenceAccession="NM_000492" sequenceVersion="3" change="c.1210-7_1210-6del">
            <Expression>NM_000492.3:c.1210-7_1210-6del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016465.4" sequenceAccession="NG_016465" sequenceVersion="4" change="g.87851_87852del">
            <Expression>NG_016465.4:g.87851_87852del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000492.4" sequenceAccession="NM_000492" sequenceVersion="4" change="c.1210-7_1210-6del" MANESelect="true">
            <Expression>NM_000492.4:c.1210-7_1210-6del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_663" sequenceAccession="LRG_663">
            <Expression>LRG_663:g.87851_87852del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_663t1" sequenceAccession="LRG_663t1">
            <Expression>LRG_663t1:c.1210-12T[5]</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Interpreted" ID="209047" DB="ClinVar" />
        <XRef ID="GTR000074114" DB="Genetic Testing Registry (GTR)" />
        <XRef Type="Allelic variant" ID="602421.0086" DB="OMIM" />
        <XRef Type="rs" ID="1805177" DB="dbSNP" />
      </XRefList>
      <GlobalMinorAlleleFrequency Value="0.02316" Source="1000 Genomes Project" MinorAllele="TTTTT" />
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000492.3(CFTR):c.1210-12T[5] AND not specified" Accession="RCV000155619" Version="30">
        <ClassifiedConditionList TraitSetID="9590">
          <ClassifiedCondition DB="MedGen" ID="CN169374">not specified</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classifications from unflagged records</ReviewStatus>
            <Description DateLastEvaluated="2024-04-08" SubmissionCount="2">no classifications from unflagged records</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.3(CFTR):c.1210-12T[5] AND Bronchiectasis with or without elevated sweat chloride 1, modifier of" Accession="RCV000007610" Version="14">
        <ClassifiedConditionList TraitSetID="1962">
          <ClassifiedCondition DB="MedGen" ID="C4017631">Bronchiectasis with or without elevated sweat chloride 1, modifier of</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-05-28" SubmissionCount="1">risk factor</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.3(CFTR):c.1210-12T[5] AND Cystic fibrosis" Accession="RCV000173692" Version="29">
        <ClassifiedConditionList TraitSetID="1961">
          <ClassifiedCondition DB="MedGen" ID="C0010674">Cystic fibrosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2023-09-04" SubmissionCount="7">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.3(CFTR):c.1210-12T[5] AND Congenital bilateral aplasia of vas deferens from CFTR mutation" Accession="RCV000007609" Version="27">
        <ClassifiedConditionList TraitSetID="6512">
          <ClassifiedCondition DB="MedGen" ID="C0403814">Congenital bilateral aplasia of vas deferens from CFTR mutation</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-07-22" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.3(CFTR):c.1210-12T[5] AND not provided" Accession="RCV000405075" Version="37">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-06-01" SubmissionCount="5">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.3(CFTR):c.1210-12T[5] AND Inborn genetic diseases" Accession="RCV001010359" Version="11">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.3(CFTR):c.1210-12T[5] AND multiple conditions" Accession="RCV001009378" Version="10">
        <ClassifiedConditionList TraitSetID="52838">
          <ClassifiedCondition>CFTR-related disorder</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0010674">Cystic fibrosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-01-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.3(CFTR):c.1210-12T[5] AND Obstructive azoospermia" Accession="RCV001706280" Version="11">
        <ClassifiedConditionList TraitSetID="40454">
          <ClassifiedCondition DB="MedGen" ID="C4023106">Obstructive azoospermia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-23" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.3(CFTR):c.1210-12T[5] AND Hereditary pancreatitis" Accession="RCV002243923" Version="9">
        <ClassifiedConditionList TraitSetID="3226">
          <ClassifiedCondition DB="MedGen" ID="C0238339">Hereditary pancreatitis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.3(CFTR):c.1210-12T[5] AND multiple conditions" Accession="RCV003330602" Version="2">
        <ClassifiedConditionList TraitSetID="12062">
          <ClassifiedCondition DB="MedGen" ID="C0403814">Congenital bilateral aplasia of vas deferens from CFTR mutation</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0010674">Cystic fibrosis</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0238339">Hereditary pancreatitis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.3(CFTR):c.1210-12T[5] AND Congenital bilateral absence of vas deferens" Accession="RCV003483594" Version="1">
        <ClassifiedConditionList TraitSetID="44370">
          <ClassifiedCondition DB="MedGen" ID="C1865433">Congenital bilateral absence of vas deferens</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-06-01" NumberOfSubmissions="24" NumberOfSubmitters="21" DateCreated="2016-05-29" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(13); Likely pathogenic(1); Uncertain significance(1); Likely benign(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">10103316</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10556281</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10668931</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11069835</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11354633</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11491164</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11729110</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1381723</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14685937</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14993601</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15371902</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15905293</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16020494</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16263954</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16778595</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16840743</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17314234</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17329263</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17489851</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18456578</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18507830</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18567645</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18685558</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19092437</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20691141</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21520337</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21658649</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22842702</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2344617</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23810505</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23974870</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25251442</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27447098</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34196078</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7506096</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7573058</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7684641</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7684646</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7691356</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7739684</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8556303</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9435322</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=CFTR</URL>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(13); Likely pathogenic(1); Uncertain significance(1); Likely benign(1)</Comment>
        <DescriptionHistory Dated="2019-08-13">
          <Description>Conflicting classifications of pathogenicity, risk factor</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-07-20">
          <Description>no classification for the single variant</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-07-20">
          <Description>Conflicting classifications of pathogenicity, risk factor</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="52838" Type="TraitChoice" ContributesToAggregateClassification="true">
            <Trait ID="42248" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CFTR-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">CFTR-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CFTR-related disorders</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CFTR-RD</ElementValue>
              </Symbol>
            </Trait>
            <Trait ID="1695" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cystic fibrosis</ElementValue>
                <XRef ID="Cystic+Fibrosis/2071" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009061" DB="MONDO" />
                <XRef Type="MIM" ID="219700" DB="OMIM" />
                <XRef ID="190905008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucoviscidosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CF</ElementValue>
                <XRef Type="MIM" ID="219700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cystic fibrosis (CF) is a multisystem disease affecting epithelia of the respiratory tract, exocrine pancreas, intestine, hepatobiliary system, and exocrine sweat glands. Morbidities include recurrent sinusitis and bronchitis, progressive obstructive pulmonary disease with bronchiectasis, exocrine pancreatic deficiency and malnutrition, pancreatitis, gastrointestinal manifestations (meconium ileus, rectal prolapse, distal intestinal obstructive syndrome), liver disease, diabetes, male infertility due to hypoplasia or aplasia of the vas deferens, and reduced fertility or infertility in some women. Pulmonary disease is the major cause of morbidity and mortality in CF.</Attribute>
                <XRef ID="NBK1250" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569983" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528606" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501921" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514611" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000005248" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558928" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569790" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556535" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529460" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570317" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592334" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000025280" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569406" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521905" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501920" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507950" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000226639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507006" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592286" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568279" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508889" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508812" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569602" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000004176" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592287" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556536" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530118" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000328569" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332363" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570019" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246717" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558875" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000277984" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592290" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508894" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000209428" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000571198" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576178" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569946" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000320929" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501918" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508810" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569426" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507003" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508811" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569791" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508893" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000074114" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569982" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508890" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508782" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330969" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507864" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507010" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6233" />
                <XRef ID="6233" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG/ACOG, 2001">
                <ID Source="PubMed">11280952</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2004">
                <ID Source="pmc">3110945</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301428</ID>
                <ID Source="BookShelf">NBK1250</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2005">
                <ID Source="PubMed">15789152</ID>
              </Citation>
              <Citation Type="general" Abbrev="CPGPT/CF FPT Committees, 2010">
                <ID Source="PubMed">20675678</ID>
              </Citation>
              <Citation Type="general" Abbrev="ECFS, 2010">
                <ID Source="PubMed">20605539</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2009">
                <ID Source="PubMed">19914445</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2009">
                <ID Source="PubMed">19914443</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG ACT Sheets, 2010">
                <ID Source="PubMed">21938795</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2022">
                <URL>https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25</URL>
                <CitationText>DailyMed Drug Label, KALYDECO- ivacaftor tablet, 2022</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG Lab QA, 2002">
                <ID Source="PubMed">12394352</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC, 2012">
                <ID Source="PubMed">22475884</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Accurso et al., 2010">
                <ID Source="pmc">3148255</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2011">
                <ID Source="PubMed">21422883</ID>
              </Citation>
              <Citation Type="general" Abbrev="CPIC, 2014">
                <ID Source="PubMed">24598717</ID>
                <ID Source="pmc">4026598</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">24014130</ID>
              </Citation>
              <Citation Type="general" Abbrev="HGS Australasia, 2014">
                <ID Source="PubMed">25431289</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Wainwright et al., 2015">
                <ID Source="PubMed">25981758</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2007">
                <ID Source="PubMed">17761616</ID>
              </Citation>
              <Citation Type="general" Abbrev="ECFS, 2018">
                <ID Source="PubMed">29506920</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2020">
                <ID Source="PubMed">32404922</ID>
                <ID Source="pmc">8268680</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Cystic-Fibrosis-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated IRT +/- DNA, Cystic Fibrosis, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2006">
                <URL>https://www.acmg.net/PDFLibrary/IRT_Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Immunoreactive Trypsinogen (IRT Elevated), 2006</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-Mutation-not-R117H.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, CFTR Mutations except R117H, Cystic Fibrosis (CF), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-Mutation-R117H.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, Cystic Fibrosis R117H, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-No-Mutation.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, No Mutations Detected by Carrier Screening, Cystic Fibrosis (CF), 2012</CitationText>
              </Citation>
              <XRef ID="586" DB="Orphanet" />
              <XRef ID="C0010674" DB="MedGen" />
              <XRef ID="MONDO:0009061" DB="MONDO" />
              <XRef Type="MIM" ID="219700" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="40454" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="29850" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Obstructive azoospermia</ElementValue>
                <XRef ID="HP:0011962" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C4023106" DB="MedGen" />
              <XRef Type="primary" ID="HP:0011962" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="12062" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="3261" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hereditary chronic pancreatitis</ElementValue>
                <XRef ID="MONDO:0008185" DB="MONDO" />
                <XRef ID="676" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary pancreatitis</ElementValue>
                <XRef ID="Hereditary+pancreatitis/3373" DB="Genetic Alliance" />
                <XRef ID="68072000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HP</ElementValue>
                <XRef Type="MIM" ID="167800" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HPC</ElementValue>
                <XRef Type="MIM" ID="167800" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CPANC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PCTT</ElementValue>
                <XRef Type="MIM" ID="167800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">SPINK1-Related Hereditary Pancreatitis</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">PRSS1-Related Hereditary Pancreatitis</Attribute>
                <XRef ID="NBK84399" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">CTRC-Related Hereditary Pancreatitis</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">CFTR-Related Hereditary Pancreatitis</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PRSS1-related hereditary pancreatitis (HP) is characterized by episodes of acute pancreatitis (AP) and recurrent acute pancreatitis (RAP: &gt;1 episode of AP), with frequent progression to chronic pancreatitis (CP). Manifestations of acute pancreatitis can range from vague abdominal pain lasting one to three days to severe abdominal pain lasting days to weeks and requiring hospitalization.</Attribute>
                <XRef ID="NBK84399" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">PCTT: PRSS1-Related Hereditary Pancreatitis</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6632" />
                <XRef ID="6632" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22379635</ID>
                <ID Source="BookShelf">NBK84399</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24624459</ID>
                <ID Source="BookShelf">NBK190101</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/ng104</URL>
                <CitationText>UK NICE Guideline NG104, Pancreatitis, 2020</CitationText>
              </Citation>
              <XRef ID="676" DB="Orphanet" />
              <XRef ID="C0238339" DB="MedGen" />
              <XRef ID="MONDO:0008185" DB="MONDO" />
              <XRef Type="MIM" ID="167800" DB="OMIM" />
            </Trait>
            <Trait ID="3944" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital bilateral aplasia of vas deferens from CFTR mutation</ElementValue>
                <XRef ID="MONDO:0010178" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CBAVD</ElementValue>
                <XRef Type="MIM" ID="277180" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CAVD</ElementValue>
                <XRef Type="MIM" ID="277180" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cystic fibrosis (CF) is a multisystem disease affecting epithelia of the respiratory tract, exocrine pancreas, intestine, hepatobiliary system, and exocrine sweat glands. Morbidities include recurrent sinusitis and bronchitis, progressive obstructive pulmonary disease with bronchiectasis, exocrine pancreatic deficiency and malnutrition, pancreatitis, gastrointestinal manifestations (meconium ileus, rectal prolapse, distal intestinal obstructive syndrome), liver disease, diabetes, male infertility due to hypoplasia or aplasia of the vas deferens, and reduced fertility or infertility in some women. Pulmonary disease is the major cause of morbidity and mortality in CF.</Attribute>
                <XRef ID="NBK1250" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000528606" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508893" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508890" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558875" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558928" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15243" />
                <XRef ID="15243" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301428</ID>
                <ID Source="BookShelf">NBK1250</ID>
              </Citation>
              <XRef ID="48" DB="Orphanet" />
              <XRef ID="C0403814" DB="MedGen" />
              <XRef ID="MONDO:0010178" DB="MONDO" />
              <XRef Type="MIM" ID="277180" DB="OMIM" />
            </Trait>
            <Trait ID="1695" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cystic fibrosis</ElementValue>
                <XRef ID="Cystic+Fibrosis/2071" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009061" DB="MONDO" />
                <XRef Type="MIM" ID="219700" DB="OMIM" />
                <XRef ID="190905008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucoviscidosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CF</ElementValue>
                <XRef Type="MIM" ID="219700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cystic fibrosis (CF) is a multisystem disease affecting epithelia of the respiratory tract, exocrine pancreas, intestine, hepatobiliary system, and exocrine sweat glands. Morbidities include recurrent sinusitis and bronchitis, progressive obstructive pulmonary disease with bronchiectasis, exocrine pancreatic deficiency and malnutrition, pancreatitis, gastrointestinal manifestations (meconium ileus, rectal prolapse, distal intestinal obstructive syndrome), liver disease, diabetes, male infertility due to hypoplasia or aplasia of the vas deferens, and reduced fertility or infertility in some women. Pulmonary disease is the major cause of morbidity and mortality in CF.</Attribute>
                <XRef ID="NBK1250" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569983" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528606" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501921" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514611" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000005248" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558928" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569790" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556535" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529460" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570317" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592334" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000025280" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569406" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521905" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501920" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507950" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000226639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507006" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592286" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568279" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508889" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508812" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569602" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000004176" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592287" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556536" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530118" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000328569" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332363" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570019" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246717" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558875" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000277984" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592290" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508894" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000209428" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000571198" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576178" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569946" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000320929" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501918" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508810" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569426" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507003" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508811" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569791" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508893" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000074114" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569982" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508890" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508782" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330969" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507864" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507010" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6233" />
                <XRef ID="6233" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG/ACOG, 2001">
                <ID Source="PubMed">11280952</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2004">
                <ID Source="pmc">3110945</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301428</ID>
                <ID Source="BookShelf">NBK1250</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2005">
                <ID Source="PubMed">15789152</ID>
              </Citation>
              <Citation Type="general" Abbrev="CPGPT/CF FPT Committees, 2010">
                <ID Source="PubMed">20675678</ID>
              </Citation>
              <Citation Type="general" Abbrev="ECFS, 2010">
                <ID Source="PubMed">20605539</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2009">
                <ID Source="PubMed">19914445</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2009">
                <ID Source="PubMed">19914443</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG ACT Sheets, 2010">
                <ID Source="PubMed">21938795</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2022">
                <URL>https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25</URL>
                <CitationText>DailyMed Drug Label, KALYDECO- ivacaftor tablet, 2022</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG Lab QA, 2002">
                <ID Source="PubMed">12394352</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC, 2012">
                <ID Source="PubMed">22475884</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Accurso et al., 2010">
                <ID Source="pmc">3148255</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2011">
                <ID Source="PubMed">21422883</ID>
              </Citation>
              <Citation Type="general" Abbrev="CPIC, 2014">
                <ID Source="PubMed">24598717</ID>
                <ID Source="pmc">4026598</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">24014130</ID>
              </Citation>
              <Citation Type="general" Abbrev="HGS Australasia, 2014">
                <ID Source="PubMed">25431289</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Wainwright et al., 2015">
                <ID Source="PubMed">25981758</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2007">
                <ID Source="PubMed">17761616</ID>
              </Citation>
              <Citation Type="general" Abbrev="ECFS, 2018">
                <ID Source="PubMed">29506920</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2020">
                <ID Source="PubMed">32404922</ID>
                <ID Source="pmc">8268680</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Cystic-Fibrosis-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated IRT +/- DNA, Cystic Fibrosis, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2006">
                <URL>https://www.acmg.net/PDFLibrary/IRT_Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Immunoreactive Trypsinogen (IRT Elevated), 2006</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-Mutation-not-R117H.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, CFTR Mutations except R117H, Cystic Fibrosis (CF), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-Mutation-R117H.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, Cystic Fibrosis R117H, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-No-Mutation.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, No Mutations Detected by Carrier Screening, Cystic Fibrosis (CF), 2012</CitationText>
              </Citation>
              <XRef ID="586" DB="Orphanet" />
              <XRef ID="C0010674" DB="MedGen" />
              <XRef ID="MONDO:0009061" DB="MONDO" />
              <XRef Type="MIM" ID="219700" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1961" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1695" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cystic fibrosis</ElementValue>
                <XRef ID="Cystic+Fibrosis/2071" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009061" DB="MONDO" />
                <XRef Type="MIM" ID="219700" DB="OMIM" />
                <XRef ID="190905008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucoviscidosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CF</ElementValue>
                <XRef Type="MIM" ID="219700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cystic fibrosis (CF) is a multisystem disease affecting epithelia of the respiratory tract, exocrine pancreas, intestine, hepatobiliary system, and exocrine sweat glands. Morbidities include recurrent sinusitis and bronchitis, progressive obstructive pulmonary disease with bronchiectasis, exocrine pancreatic deficiency and malnutrition, pancreatitis, gastrointestinal manifestations (meconium ileus, rectal prolapse, distal intestinal obstructive syndrome), liver disease, diabetes, male infertility due to hypoplasia or aplasia of the vas deferens, and reduced fertility or infertility in some women. Pulmonary disease is the major cause of morbidity and mortality in CF.</Attribute>
                <XRef ID="NBK1250" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569983" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528606" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501921" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514611" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000005248" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558928" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569790" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556535" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529460" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570317" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592334" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000025280" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569406" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521905" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501920" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507950" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000226639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507006" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592286" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568279" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508889" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508812" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569602" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000004176" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592287" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556536" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530118" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000328569" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332363" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570019" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246717" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558875" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000277984" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592290" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508894" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000209428" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000571198" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576178" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569946" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000320929" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501918" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508810" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569426" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507003" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508811" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569791" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508893" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000074114" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569982" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508890" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508782" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330969" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507864" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507010" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6233" />
                <XRef ID="6233" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG/ACOG, 2001">
                <ID Source="PubMed">11280952</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2004">
                <ID Source="pmc">3110945</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301428</ID>
                <ID Source="BookShelf">NBK1250</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2005">
                <ID Source="PubMed">15789152</ID>
              </Citation>
              <Citation Type="general" Abbrev="CPGPT/CF FPT Committees, 2010">
                <ID Source="PubMed">20675678</ID>
              </Citation>
              <Citation Type="general" Abbrev="ECFS, 2010">
                <ID Source="PubMed">20605539</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2009">
                <ID Source="PubMed">19914445</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2009">
                <ID Source="PubMed">19914443</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG ACT Sheets, 2010">
                <ID Source="PubMed">21938795</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2022">
                <URL>https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25</URL>
                <CitationText>DailyMed Drug Label, KALYDECO- ivacaftor tablet, 2022</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG Lab QA, 2002">
                <ID Source="PubMed">12394352</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC, 2012">
                <ID Source="PubMed">22475884</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Accurso et al., 2010">
                <ID Source="pmc">3148255</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2011">
                <ID Source="PubMed">21422883</ID>
              </Citation>
              <Citation Type="general" Abbrev="CPIC, 2014">
                <ID Source="PubMed">24598717</ID>
                <ID Source="pmc">4026598</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">24014130</ID>
              </Citation>
              <Citation Type="general" Abbrev="HGS Australasia, 2014">
                <ID Source="PubMed">25431289</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Wainwright et al., 2015">
                <ID Source="PubMed">25981758</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2007">
                <ID Source="PubMed">17761616</ID>
              </Citation>
              <Citation Type="general" Abbrev="ECFS, 2018">
                <ID Source="PubMed">29506920</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2020">
                <ID Source="PubMed">32404922</ID>
                <ID Source="pmc">8268680</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Cystic-Fibrosis-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated IRT +/- DNA, Cystic Fibrosis, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2006">
                <URL>https://www.acmg.net/PDFLibrary/IRT_Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Immunoreactive Trypsinogen (IRT Elevated), 2006</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-Mutation-not-R117H.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, CFTR Mutations except R117H, Cystic Fibrosis (CF), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-Mutation-R117H.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, Cystic Fibrosis R117H, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-No-Mutation.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, No Mutations Detected by Carrier Screening, Cystic Fibrosis (CF), 2012</CitationText>
              </Citation>
              <XRef ID="586" DB="Orphanet" />
              <XRef ID="C0010674" DB="MedGen" />
              <XRef ID="MONDO:0009061" DB="MONDO" />
              <XRef Type="MIM" ID="219700" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1962" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="10302" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Bronchiectasis with or without elevated sweat chloride 1, modifier of</ElementValue>
              </Name>
              <XRef ID="C4017631" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6512" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3944" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital bilateral aplasia of vas deferens from CFTR mutation</ElementValue>
                <XRef ID="MONDO:0010178" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CBAVD</ElementValue>
                <XRef Type="MIM" ID="277180" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CAVD</ElementValue>
                <XRef Type="MIM" ID="277180" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cystic fibrosis (CF) is a multisystem disease affecting epithelia of the respiratory tract, exocrine pancreas, intestine, hepatobiliary system, and exocrine sweat glands. Morbidities include recurrent sinusitis and bronchitis, progressive obstructive pulmonary disease with bronchiectasis, exocrine pancreatic deficiency and malnutrition, pancreatitis, gastrointestinal manifestations (meconium ileus, rectal prolapse, distal intestinal obstructive syndrome), liver disease, diabetes, male infertility due to hypoplasia or aplasia of the vas deferens, and reduced fertility or infertility in some women. Pulmonary disease is the major cause of morbidity and mortality in CF.</Attribute>
                <XRef ID="NBK1250" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000528606" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508893" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508890" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558875" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558928" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15243" />
                <XRef ID="15243" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301428</ID>
                <ID Source="BookShelf">NBK1250</ID>
              </Citation>
              <XRef ID="48" DB="Orphanet" />
              <XRef ID="C0403814" DB="MedGen" />
              <XRef ID="MONDO:0010178" DB="MONDO" />
              <XRef Type="MIM" ID="277180" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="16789" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not specified</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
              </AttributeSet>
              <XRef ID="CN169374" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3226" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3261" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hereditary chronic pancreatitis</ElementValue>
                <XRef ID="MONDO:0008185" DB="MONDO" />
                <XRef ID="676" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary pancreatitis</ElementValue>
                <XRef ID="Hereditary+pancreatitis/3373" DB="Genetic Alliance" />
                <XRef ID="68072000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HP</ElementValue>
                <XRef Type="MIM" ID="167800" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HPC</ElementValue>
                <XRef Type="MIM" ID="167800" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CPANC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PCTT</ElementValue>
                <XRef Type="MIM" ID="167800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">SPINK1-Related Hereditary Pancreatitis</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">PRSS1-Related Hereditary Pancreatitis</Attribute>
                <XRef ID="NBK84399" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">CTRC-Related Hereditary Pancreatitis</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">CFTR-Related Hereditary Pancreatitis</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PRSS1-related hereditary pancreatitis (HP) is characterized by episodes of acute pancreatitis (AP) and recurrent acute pancreatitis (RAP: &gt;1 episode of AP), with frequent progression to chronic pancreatitis (CP). Manifestations of acute pancreatitis can range from vague abdominal pain lasting one to three days to severe abdominal pain lasting days to weeks and requiring hospitalization.</Attribute>
                <XRef ID="NBK84399" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">PCTT: PRSS1-Related Hereditary Pancreatitis</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6632" />
                <XRef ID="6632" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22379635</ID>
                <ID Source="BookShelf">NBK84399</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24624459</ID>
                <ID Source="BookShelf">NBK190101</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/ng104</URL>
                <CitationText>UK NICE Guideline NG104, Pancreatitis, 2020</CitationText>
              </Citation>
              <XRef ID="676" DB="Orphanet" />
              <XRef ID="C0238339" DB="MedGen" />
              <XRef ID="MONDO:0008185" DB="MONDO" />
              <XRef Type="MIM" ID="167800" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="44370" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="43497" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital bilateral absence of vas deferens</ElementValue>
                <XRef ID="MONDO:0018801" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Vas deferens, congenital bilateral aplasia of</Attribute>
                <XRef Type="Phenotypic series" ID="PS277180" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5461" />
                <XRef ID="5461" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="48" DB="Orphanet" />
              <XRef ID="C1865433" DB="MedGen" />
              <XRef ID="MONDO:0018801" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS277180" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="780029" SubmissionDate="2016-10-18" DateLastUpdated="2016-12-06" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="499668|CFTR-Related Disorders" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000466508" DateUpdated="2016-12-06" DateCreated="2016-12-06" Type="SCV" Version="2" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-06-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely benign</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification 20161018</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/r4jv4v98/icsl_variant_classification_20161018.pdf</URL>
            <CitationText>ICSL_Variant_Classification_20161018.pdf</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.1210-7_1210-6delTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CFTR-Related Disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>ICSL_2016Q4</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="643010" SubmissionDate="2017-11-28" DateLastUpdated="2017-12-19" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="GDX:536112|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000329660" DateUpdated="2017-12-19" DateCreated="2016-12-06" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-07-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1210-7_1210-6delTT variant in the CFTR gene, also reported as c.1210-12T[5] and commonly referred to as the 5T allele, occurs in the poly T tract in intron 9 (intron 8 using legacy exon numbering). The c.1210-7_1210-6delTT variant acts as a disease susceptibility variant with variable penetrance (CFTR2 Mutation Database; Ong et al., 2017). Specifically, the c.1210-7_1210-6delTT variant has been associated with recessive CFTR-related disorders when seen in trans with another severe pathogenic variant in the CFTR gene. Disease features described include elevated sweat chloride levels, congenital bilateral absence of the vas deferens (CBAVD) in males, and non-classic to classic cystic fibrosis (Chillon et al., 1995; Ong et al., 2017). However, the penetrance of the c.1210-7_1210-6delTT variant is influenced by the presence of other variants (e.g. R117H) and the length of the adjacent TG tract on the same allele (in cis). Longer TG repeat sizes (TG12 and TG13) in cis with c.1210-7_1210-6delTT are associated with a greater susceptibility to disease than c.1210-7_1210-6delTT in cis with a smaller TG repeat size (TG11) (Cuppens et al., 1998; Groman et al., 2004; Ong et al., 2017). RNA studies demonstrate that the c.1210-7_1210-6delTT variant results in abnormal splicing of exon 10 in a significant percentage of transcripts (Chu et al., 1993; Hefferon et al., 2002). The c.1210-7_1210-6delTT variant has been observed in at least 5% of alleles from of individuals of European background (Chillon et al., 1995). Therefore, based on the information available, we interpret c.1210-7_1210-6delTT as a pathogenic susceptibility variant with variable penetrance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.1210-7_1210-6delTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="645090" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-15" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="20720_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000331631" DateUpdated="2018-12-15" DateCreated="2016-12-06" Type="SCV" Version="4" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000224836" DateChanged="2019-08-06" Version="4">
            <Comment Type="MergeComment">SCV000224836 was merged into SCV000331631 to remove duplication.</Comment>
          </Replaced>
          <Replaced Accession="SCV000224835" DateChanged="2019-08-06" Version="4">
            <Comment Type="MergeComment">SCV000224835 was merged into SCV000331631 to remove duplication.</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2017-03-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="177" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="67" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" alternateAllele="-" referenceAllele="TT" start="117188688" stop="117188689" variantLength="2" />
            <GeneLocation>NM_000492.3:IVS9</GeneLocation>
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=CFTR</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL005</SubmissionName>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="367423" SubmissionDate="2019-03-21" DateLastUpdated="2016-05-29" DateCreated="2015-01-31">
        <ClinVarSubmissionID localKey="38711660|not specified" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000205327" DateUpdated="2016-05-29" DateCreated="2015-01-31" Type="SCV" Version="4" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-01-14">
          <ReviewStatus>flagged submission</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14685937</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7506096</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11069835</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17314234</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16020494</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7739684</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1381723</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7684646</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16263954</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9435322</ID>
          </Citation>
          <Comment>The c.1210-34TG[11]T[5] in intron 9 of CFTR is a variant of the polymorphic TG[n ]T[m] region adjacent to exon 10. The T[5] allele has been identified in an ave rage of 4.3% of individuals from a population of European American chromosomes ( Groman 2004) and has been shown to affect splicing in small percentage of transc ripts (Chu 1993). The length of the TG tract modifies the overall risk with lon ger TG repeat sizes (TG 12 and 13) showing the greatest susceptibility to diseas e when present in trans with a pathogenic cystic fibrosis variant (Chu 1992, Cup pens 1998, Groman 2004, Radpour 2007). The combination of the T[5] and TG[11] is least likely to exhibit an abnormal phenotype but a modest increased risk canno t be excluded (Cuppens 1998; Groman 2004). The associated CF-related symptoms ar e congenital bilateral absence of the vas deferens (CBAVD), male infertility, mi ld to classic forms of cystic fibrosis, with severity depending of the CF varian t on the opposite allele (Chillon 1995). In summary, the clinical significance o f the 1210-34TG[11]T[5] is uncertain.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="2" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000492.3:INTRON 9</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_000492.3:c.1210-7_1210-6delTT</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.117188688_117188689delTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not specified</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Comment DataSource="ClinGen" Type="FlaggedComment">Notes: None</Comment>
        <Comment DataSource="ClinGen" Type="FlaggedComment">Reason: Outlier claim with insufficient supporting evidence</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB5348977</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2307212" SubmissionDate="2019-09-16" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="c.1210-12T[5]|cystic fibrosis;CFTR-related disorders" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001169231" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="CFTR-France" OrgID="507119" OrganizationCategory="locus-specific database (LSDB)" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-01-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>when the variant is in trans with another CF-causing variation, can either result in CF or in a CFTR-RD</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Claustres M et al. (Hum Mutat 2017)</Attribute>
          <Citation>
            <ID Source="PubMed">28603918</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.1210-12T[5]</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">cystic fibrosis</ElementValue>
            </Name>
          </Trait>
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CFTR-related disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28603918</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB6300041</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2354254" SubmissionDate="2020-01-15" DateLastUpdated="2020-04-06" DateCreated="2020-04-06">
        <ClinVarSubmissionID localKey=":Chr.7_117188682_117188684_GTT_G|OMIM:219700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001193799" DateUpdated="2020-04-06" DateCreated="2020-04-06" Type="SCV" Version="1" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-10-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23974870</ID>
          </Citation>
          <Comment>NM_000492.3(CFTR):c.1210-7_1210-6delTT(aka IVS8-5T or 5T) is a variant within the polyT tract located within intron 8 of the CFTR gene. 5T has been observed in individuals diagnosed with cystic fibrosis but has also been observed in healthy individuals (PMID 23974870; gnomAD: AFR 7.085%). Please note that 5T is not associated with cystic fibrosis when detected in isolation and the American College of Medical Genetics does not recommend reporting 5T status through routine carrier screening when detected in isolation. However, 5T is considered an incompletely penetrant pathogenic variant that may result in cystic fibrosis when present on the same chromosome as R117H and combined with another pathogenic CFTR variant on the other chromosome. In the absence of R117H, 5T may be associated with CFTR-related disorders depending on the presence of other deleterious variants in the gene. In summary, classification of 5T is based on the following criteria: high frequency variant with incomplete penetrance and variable severity dependent on the presence of other variants in the CFTR gene. Please note: this allele was assessed in the context of healthy population screening.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2019)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/vlxza0ea/myriad_women_s_health_autosomal_recessive_and_x-linked_classification_criteria_2019_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" alternateAllele="G" referenceAllele="GTT" start="117188682" stop="117188684" variantLength="3" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="219700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6849778</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2670962" SubmissionDate="2020-03-06" DateLastUpdated="2020-06-22" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="NM_000492.3:c.1210-12[5]|MedGen:C0403814" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001362614" DateUpdated="2020-06-22" DateCreated="2020-06-22" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-11-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19092437</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11354633</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7684646</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9435322</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14685937</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17329263</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15905293</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17489851</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11729110</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20691141</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18456578</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21520337</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14993601</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16840743</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18685558</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23810505</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22842702</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16778595</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25251442</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10668931</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18567645</ID>
          </Citation>
          <Comment>Variant summary: CFTR c.1210-12[5] (also known as c.5T_TG11 or c.1210-7_1210-6delTT) occurs in the poly T tract in intron 9. 5/5 computational tools predict no significant impact on normal splicing. However, at least one functional study shows a moderate impact to proper CFTR mRNA expression in vitro (Hefferon_2004). The variant has been reported in the literature in numerous individuals affected with Congenital Bilateral Absence of the Vas Deferens, as well as some individuals who are asymptomatic. The variant is associated with CFTR-related disorders when in trans with another severe pathogenic CFTR variant. The penetrance of the c.1210-12[5] variant is influenced by the presence of other variants (e.g. R117H) and the length of the adjacent TG tract on the same allele (in cis). Seven clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014, four of which classified the variant as pathogenic. In addition, ACMG guidelines for reporting CFTR mutations consider the 5T allele as associated as a trans mutation in CBAVD (ACMG guideline_2011). Based on the evidence outlined above, the variant was classified as pathogenic for CBAVD and CFTR-related disorders.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.1210-12[5]</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Congenital bilateral aplasia of vas deferens from CFTR mutation</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0403814" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6913290</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="27810" SubmissionDate="2021-08-06" DateLastUpdated="2021-08-14" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="602421.0086_VAS DEFERENS, CONGENITAL BILATERAL ABSENCE OF" title="CFTR, IVS8AS, 5T VARIANT_VAS DEFERENS, CONGENITAL BILATERAL ABSENCE OF" />
        <ClinVarAccession Accession="SCV000027810" DateUpdated="2021-08-14" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-05-28">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Zielenski et al. (1995) estimated that CBAVD (277180) is associated with the 5T variant at the 3-prime end of intron 8 of the CFTR gene with a penetrance of 0.60 in males. Chu et al. (1993) noted varied lengths of a thymidine (T)-tract (5, 7, or 9T) in front of the splice-acceptor site of intron 8. The length appeared to correlate with the efficiency of exon 9 splicing, with the 5T variant that is present in 5% of the CFTR alleles among the Caucasian population producing almost exclusively (95%) exon 9-minus mRNA. The effect of this T-tract polymorphism in CFTR gene expression was also documented by its relationship with the CF mutation R117H (602421.0005): while R117H (5T) is found in typical CF patients with pancreatic sufficiency, R117H (7T) is associated with CBAVD (Kiesewetter et al., 1993).</Attribute>
              <Citation>
                <ID Source="PubMed">7573058</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">7684646</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">7506096</ID>
              </Citation>
              <XRef DB="OMIM" ID="277180" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Costes et al. (1995) studied the CFTR gene in 45 azoospermic individuals with isolated CBAVD. They detected a CFTR gene defect in 86% of chromosomes from these subjects. In addition to identifying 9 novel CFTR gene mutations, they found that 84% of men with CBAVD who were heterozygous for a CF mutation carried the intron 8 polypyrimidine 5T CFTR allele on 1 chromosome.</Attribute>
              <Citation>
                <ID Source="PubMed">8556303</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">De Meeus et al. (1998) found linkage disequilibrium between the 5T allele and the val allele of the met470-to-val polymorphism (602421.0023).</Attribute>
              <Citation>
                <ID Source="PubMed">2344617</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Groman et al. (2004) demonstrated that the number of TG repeats adjacent to 5T influences disease penetrance. They determined TG repeat number in 98 patients with male infertility due to congenital absence of the vas deferens, 9 patients with nonclassic CF, and 27 unaffected individuals (fertile men). Each of the individuals in this study had a severe CFTR mutation on one CFTR gene and 5T on the other. They found that those individuals with 5T adjacent to either 12 or 13 TG repeats were substantially more likely to exhibit an abnormal phenotype than those with 5T adjacent to 11 TG repeats. Thus, determination of TG repeat number will allows for more accurate prediction of benign versus pathogenic 5T alleles.</Attribute>
              <Citation>
                <ID Source="PubMed">14685937</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">The TG repeat located at the splice acceptor site of exon 9 of the CFTR gene is an example of a variable dinucleotide repeat that affects splicing. Higher repeat numbers result in reduced exon 9 splicing efficiency and, in some instances, the reduction in full-length transcript is sufficient to cause male infertility due to congenital bilateral absence of the vas deferens or nonclassic cystic fibrosis. Using a CFTR minigene system, Hefferon et al. (2004) studied TG tract variation and observed the same correlation between dinucleotide repeat number and exon 9 splicing efficiency seen in vivo. Replacement of the TG dinucleotide tract in the minigene with random sequence abolished splicing of exon 9. Replacements of the TG tract with sequences that can self-basepair suggested that the formation of an RNA secondary structure was associated with efficient splicing. However, splicing efficiency was inversely correlated with the predicted thermodynamic stability of such structures, demonstrating that intermediate stability was optimal. Finally, substitution of TA repeats of differing lengths confirmed that stability of the RNA secondary structure, not sequence content, correlated with splicing efficiency. Taken together, these data indicated that dinucleotide repeats can form secondary structures that have variable effects on RNA splicing efficiency and clinical phenotype.</Attribute>
              <Citation>
                <ID Source="PubMed">14993601</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 66-year-old woman and an unrelated 67-year-old man with idiopathic bronchiectasis (BESC1; 211400), who were heterozygous for the 5T CFTR variant, Fajac et al. (2008) also identified heterozygosity for a missense mutation in the SCNN1B gene (600760.0015). The woman had a borderline elevated sweat chloride, normal nasal potential difference (PD), and FEV1 that was 77% of predicted. The man had normal sweat chloride and nasal PD, and FEV1 that was 80% of predicted. Fajac et al. (2008) concluded that variants in SCNN1B may be deleterious for sodium channel function and lead to bronchiectasis, especially in patients who also carry a mutation in the CFTR gene.</Attribute>
              <Citation>
                <ID Source="PubMed">18507830</ID>
              </Citation>
              <XRef DB="OMIM" ID="211400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <Name>CFTR, IVS8AS, 5T VARIANT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">IVS8AS, 5T VARIANT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602421.0086" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">VAS DEFERENS, CONGENITAL BILATERAL ABSENCE OF</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="88865" SubmissionDate="2021-08-06" DateLastUpdated="2021-08-14" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="602421.0086_BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1, MODIFIER OF" title="CFTR, IVS8AS, 5T VARIANT_BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1, MODIFIER OF" />
        <ClinVarAccession Accession="SCV000053489" DateUpdated="2021-08-14" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-05-28">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>risk factor</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Zielenski et al. (1995) estimated that CBAVD (277180) is associated with the 5T variant at the 3-prime end of intron 8 of the CFTR gene with a penetrance of 0.60 in males. Chu et al. (1993) noted varied lengths of a thymidine (T)-tract (5, 7, or 9T) in front of the splice-acceptor site of intron 8. The length appeared to correlate with the efficiency of exon 9 splicing, with the 5T variant that is present in 5% of the CFTR alleles among the Caucasian population producing almost exclusively (95%) exon 9-minus mRNA. The effect of this T-tract polymorphism in CFTR gene expression was also documented by its relationship with the CF mutation R117H (602421.0005): while R117H (5T) is found in typical CF patients with pancreatic sufficiency, R117H (7T) is associated with CBAVD (Kiesewetter et al., 1993).</Attribute>
              <Citation>
                <ID Source="PubMed">7573058</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">7684646</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">7506096</ID>
              </Citation>
              <XRef DB="OMIM" ID="277180" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Costes et al. (1995) studied the CFTR gene in 45 azoospermic individuals with isolated CBAVD. They detected a CFTR gene defect in 86% of chromosomes from these subjects. In addition to identifying 9 novel CFTR gene mutations, they found that 84% of men with CBAVD who were heterozygous for a CF mutation carried the intron 8 polypyrimidine 5T CFTR allele on 1 chromosome.</Attribute>
              <Citation>
                <ID Source="PubMed">8556303</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">De Meeus et al. (1998) found linkage disequilibrium between the 5T allele and the val allele of the met470-to-val polymorphism (602421.0023).</Attribute>
              <Citation>
                <ID Source="PubMed">2344617</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Groman et al. (2004) demonstrated that the number of TG repeats adjacent to 5T influences disease penetrance. They determined TG repeat number in 98 patients with male infertility due to congenital absence of the vas deferens, 9 patients with nonclassic CF, and 27 unaffected individuals (fertile men). Each of the individuals in this study had a severe CFTR mutation on one CFTR gene and 5T on the other. They found that those individuals with 5T adjacent to either 12 or 13 TG repeats were substantially more likely to exhibit an abnormal phenotype than those with 5T adjacent to 11 TG repeats. Thus, determination of TG repeat number will allows for more accurate prediction of benign versus pathogenic 5T alleles.</Attribute>
              <Citation>
                <ID Source="PubMed">14685937</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">The TG repeat located at the splice acceptor site of exon 9 of the CFTR gene is an example of a variable dinucleotide repeat that affects splicing. Higher repeat numbers result in reduced exon 9 splicing efficiency and, in some instances, the reduction in full-length transcript is sufficient to cause male infertility due to congenital bilateral absence of the vas deferens or nonclassic cystic fibrosis. Using a CFTR minigene system, Hefferon et al. (2004) studied TG tract variation and observed the same correlation between dinucleotide repeat number and exon 9 splicing efficiency seen in vivo. Replacement of the TG dinucleotide tract in the minigene with random sequence abolished splicing of exon 9. Replacements of the TG tract with sequences that can self-basepair suggested that the formation of an RNA secondary structure was associated with efficient splicing. However, splicing efficiency was inversely correlated with the predicted thermodynamic stability of such structures, demonstrating that intermediate stability was optimal. Finally, substitution of TA repeats of differing lengths confirmed that stability of the RNA secondary structure, not sequence content, correlated with splicing efficiency. Taken together, these data indicated that dinucleotide repeats can form secondary structures that have variable effects on RNA splicing efficiency and clinical phenotype.</Attribute>
              <Citation>
                <ID Source="PubMed">14993601</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 66-year-old woman and an unrelated 67-year-old man with idiopathic bronchiectasis (BESC1; 211400), who were heterozygous for the 5T CFTR variant, Fajac et al. (2008) also identified heterozygosity for a missense mutation in the SCNN1B gene (600760.0015). The woman had a borderline elevated sweat chloride, normal nasal potential difference (PD), and FEV1 that was 77% of predicted. The man had normal sweat chloride and nasal PD, and FEV1 that was 80% of predicted. Fajac et al. (2008) concluded that variants in SCNN1B may be deleterious for sodium channel function and lead to bronchiectasis, especially in patients who also carry a mutation in the CFTR gene.</Attribute>
              <Citation>
                <ID Source="PubMed">18507830</ID>
              </Citation>
              <XRef DB="OMIM" ID="211400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <Name>CFTR, IVS8AS, 5T VARIANT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">IVS8AS, 5T VARIANT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602421.0086" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1, MODIFIER OF</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3563150" SubmissionDate="2021-09-01" DateLastUpdated="2021-09-08" DateCreated="2021-09-08">
        <ClinVarSubmissionID localKey="NM_000492.3:c.1210-12T[5]|OMIM:277180" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001822040" DateUpdated="2021-09-08" DateCreated="2021-09-08" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.1210-12T[5]</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="277180" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10301801</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3799850" SubmissionDate="2021-09-22" DateLastUpdated="2021-09-26" DateCreated="2021-09-26">
        <ClinVarSubmissionID localKey="10001|HPO:HP:0011962" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001911515" DateUpdated="2021-09-26" DateCreated="2021-09-26" Type="SCV" Version="1" SubmitterName="Institute of Reproductive Genetics, University of Mnster" OrgID="506832" OrganizationCategory="laboratory" OrgAbbreviation="IRG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="4" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.1210-12T[5]</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0011962" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10409859</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3877961" SubmissionDate="2021-10-04" DateLastUpdated="2021-10-30" DateCreated="2021-10-30">
        <ClinVarSubmissionID localKey="NM_000492.3:c.1210-7_1210-6delTT|not specified" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001984010" DateUpdated="2021-10-30" DateCreated="2021-10-30" Type="SCV" Version="1" SubmitterName="Al Jalila Childrens Genomics Center, Al Jalila Childrens Speciality Hospital" OrgID="507199" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-08">
          <ReviewStatus>flagged submission</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.1210-7_1210-6delTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not specified</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Comment>The c.1210-12T[5] variant also referred to as the 5T allele occurs in the poly T tract in intron 8 of the CFTR gene. This variant acts as a disease susceptibility variant with reduced penetrance and variable expressivity1. Specifically the 5T variant has been associated with recessive CFTR-related disorders when seen in trans with another severe pathogenic variant in the CFTR gene. Disease features described include elevated sweat chloride levels congenital bilateral absence of the vas deferens (CBAVD) in males and non-classic to classic cystic fibrosis12. However the penetrance of the 5T allele is influenced by the presence of other variants (e.g. R117H) and the length of the adjacent TG tract on the same allele (in cis). Longer TG repeat sizes (TG12 and TG13) in cis with 5T are associated with a greater susceptibility to disease than when in cis with a smaller TG repeat size (TG11)134. RNA studies demonstrate that the c.1210-12T[5] variant affects mRNA splicing56. The c.1210-12T[5] variant has been observed in 7% (1260/17968 25 homozygotes) and 2.9% (3015/103332 13 homozygotes) African and European Non Finnish alleles respectively. Therefore based on the information available we interpret c.1210-12T[5] as a pathogenic variant with reduced penetrance and variable expressivity. 1. Ong T Marshall S. Karczeski B. et al. Cystic Fibrosis and Congenital Absence of the Vas Deferens. 2001 Mar 26 [Updated 2017 Feb 2]. In: Adam MP Ardinger HH Pagon RA et al. editors. GeneReviews [Internet]. Seattle (WA): University of Washington Seattle 1993-2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1250/ 2. Chilln M. Casals T. et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med. Jun 1332(22):1475-80. (1995) 3. Cuppens H Lin W Jaspers M et al. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest.101(2):487496. (1998) 4 Groman JD Hefferon TW Casals T et al. Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign. Am J Hum Genet.74(1):176179.(2004) 5 Chu CS Trapnell BC Curristin SM Cutting GR Crystal RG. Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis. J Clin Invest. 90(3):785790. (1992) 6. Hefferon TW Broackes-Carter FC Harris A Cutting GR. Atypical 5' splice sites cause CFTR exon 9 to be vulnerable to skipping. Am J Hum Genet. 71(2):294303. (2002)</Comment>
        <Comment DataSource="NCBI" Type="FlaggedComment">Reason: This record appears to be redundant with a more recent record from the same submitter.</Comment>
        <Comment DataSource="NCBI" Type="FlaggedComment">Notes: SCV001984010 appears to be redundant with SCV002818248.</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB10465084</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3112850" SubmissionDate="2022-05-04" DateLastUpdated="2022-05-16" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="10773|MedGen:C0010674" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001587195" DateUpdated="2022-05-16" DateCreated="2021-05-10" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14685937</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14685937</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27447098</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16778595</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21520337</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34196078</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7691356</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7684641</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10556281</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14685937</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21658649</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14685937</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10556281</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9435322</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10556281</ID>
          </Citation>
          <Comment>This sequence change, also referred to as 5T;TG11 or TG11-5T in the literature, consists of 11 TG and 5 T sequence repeats on the same chromosome, and is located in intron 9 of the CFTR gene. It does not directly change the encoded amino acid sequence of the CFTR protein. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. The TG[11]T[5] allele has been observed in males with congenital bilateral absence of the vas deferens (CBAVD), with a penetrance of ~32%, when present on the opposite chromosome (in trans) from a severe pathogenic CFTR variant (PMID: 14685937). The TG[11]T[5] allele is not expected to cause cystic fibrosis in either males or females when in trans with a severe pathogenic CFTR variant (PMID: 14685937, 27447098), although individuals with borderline sweat chloride results and/or mild respiratory disease have been reported (PMID: 16778595). The combination of the TG[11]T[5] allele in trans with another 5T allele (TG11-13), is unlikely to be associated with CFTR-related symptoms (PMID: 21520337, 34196078). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies demonstrate that the 5T allele leads to exclusion of exon 10 (referred to as exon 9 in some publications) from the mRNA, which ultimately results in a non-functional CFTR protein (PMID: 7691356, 7684641, 10556281, 14685937, 21658649) and partial loss of function. Importantly, the number of TG repeats (11, 12 or 13) modifies the extent of exon 10 skipping when in cis with the 5T allele (PMID: 14685937, 10556281, 9435322). In a mini-gene assay, the percentage of CFTR mRNA without exon 10 was 54% for TG[11]T[5], 72% for TG[12]T[5] and 100% for TG[13]T[5] (PMID: 10556281). In summary, this variant is reported to cause disease. However, as this variant is associated with a lower penetrance than other pathogenic alleles in the CFTR gene, it has been classified as Pathogenic (low penetrance).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.117188683_117188684del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0010674" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4924016" SubmissionDate="2022-05-11" DateLastUpdated="2022-05-21" DateCreated="2022-05-21">
        <ClinVarSubmissionID localKey="NM_000492.4:c.1210-7_1210-6del|OMIM:167800" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002512245" DateUpdated="2022-05-21" DateCreated="2022-05-21" Type="SCV" Version="1" SubmitterName="Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein" OrgID="508506" OrganizationCategory="laboratory" OrgAbbreviation="LABO-HIAE" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ACMG classification criteria: PS3 supporting, PS4 strong, PM3 very strong</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Brazil</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.4:c.1210-7_1210-6del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="167800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11461911</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3224948" SubmissionDate="2021-05-21" DateLastUpdated="2022-10-01" DateCreated="2021-05-23">
        <ClinVarSubmissionID localKey="NM_000492.3:c.1210-12T[5]|OMIM:219700" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV001652691" DateUpdated="2022-10-01" DateCreated="2021-05-23" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15371902</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11491164</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7506096</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10103316</ID>
          </Citation>
          <Comment>The severity of lung disease in individuals heterozygous or homozygous for p.Arg117His depends on the presence of a variation in the poly T tract of intron 9, c.1210-12T[5_9] [Massie et al 2001]. Individuals with a CF-causing variant plus the 5T variant in cis with p.Arg117His usually develop the lung disease of CF, but those individuals with p.Arg117His and the 7T variant or the 9T variant have a highly variable phenotype that can range from no symptoms to mild lung disease [Kiesewetter et al 1993, Chmiel et al 1999].</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>5T/7T/9T</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.1210-12T[5]</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0010674" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Abbrev="GeneReviews" Type="review">
          <ID Source="PubMed">20301428</ID>
          <ID Source="BookShelf">NBK1250</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
          <SubmissionName>SUB9705203</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1732917" SubmissionDate="2018-11-11" DateLastUpdated="2022-12-11" DateCreated="2018-07-20">
        <ClinVarSubmissionID localKey="NC_000007.13:g.117188683_117188684delTT|OMIM:219700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000886265" DateUpdated="2022-12-11" DateCreated="2018-07-20" Type="SCV" Version="2" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-11-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.117188683_117188684delTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="219700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_014</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2310536" SubmissionDate="2020-11-30" DateLastUpdated="2023-03-04" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="a5095" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001170545" DateUpdated="2023-03-04" DateCreated="2020-03-16" Type="SCV" Version="3" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The 5T variant, located in intron 9 of the CFTR gene, is an alteration within the poly-thymidine tract, which decreases the efficiency of exon 10 splicing. The 5T variant in trans with a pathogenic CFTR mutation, or in the homozygous state, has been associated with CFTR-related disorders, including bronchiectasis (Sosnay PR et al. Pediatr. Clin. North Am., 2016 08;63:585-98), acute recurrent or chronic pancreatitis (Werlin S et al. J. Pediatr. Gastroenterol. Nutr., 2015 May;60:675-9; Masson E et al. PLoS ONE, 2013 Aug;8:e73522), and congenital bilateral absence of the vas deferens (CBAVD) (Bombieri C et al. J. Cyst. Fibros., 2011 Jun;10 Suppl 2:S86-102). The effect of 5T on exon 10 splicing is influenced by the adjacent TG tract, which usually consists of 11, 12, or 13 TG repeats. Increasing TG tract length correlates with decreased amount of full-length CFTR, thereby leading to higher likelihood of a cystic fibrosis phenotype (Sosnay PR et al. Pediatr. Clin. North Am., 2016 08;63:585-98); information regarding the number of TG repeats adjacent to the 5T allele is limited in pancreatitis and bronchiectasis research (Mantovani V et al. Clin. Chem., 2007 Mar;53:531-3; Bombieri C et al. J. Cyst. Fibros., 2011 Jun;10 Suppl 2:S86-102).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Autosomal Dominant and X-Linked criteria (3/2017)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/10Jq49tz/AD_XL_ClassificationScheme_03.2017_Ambry.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.1210-7_1210-6del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4016164" SubmissionDate="2024-01-24" DateLastUpdated="2024-02-20" DateCreated="2022-01-08">
        <ClinVarSubmissionID localKey="2206059|MedGen:CN235283" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002047826" DateUpdated="2024-02-20" DateCreated="2022-01-08" Type="SCV" Version="7" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000602990" DateChanged="2023-06-09" Version="1">
            <Comment Type="MergeComment">SCV000602990 was merged into SCV002047826 because sCV000602990 was merged into SCV002047826 to remove duplication</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2023-11-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The 11TG-5T variant in IVS8 is the mildest type of 5T variant. When combined with a pathogenic variant on the other chromosome, this variant is not expected to cause classic cystic fibrosis (CF), but may cause a CFTR-related disorder (i.e., an isolated presentation of pancreatitis, congenital bilateral absence of the vas deferens, or mild lung disease) (CFTR2 database). Link to CFTR2 database: http://cftr2.org/</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process 2024</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/xwiqgyug/arup_molecular_germline_variant_investigation_process_arup-info-0022_2024.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.117188688_117188689del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN235283" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2022 ARUP ClinVar submission</SubmissionName>
          <SubmissionName>2023 ARUP ClinVar submission</SubmissionName>
          <SubmissionName>ARUP Molecular 2021</SubmissionName>
          <SubmissionName>May 2022</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1354337" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2017-12-19">
        <ClinVarSubmissionID localKey="9255|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000693251" DateUpdated="2024-07-15" DateCreated="2017-12-19" Type="SCV" Version="21" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-06-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>CFTR: PM3:Very Strong, PS3:Moderate, PM2:Supporting, BP4</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="13" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" alternateAllele="T" referenceAllele="TTT" start="117188687" stop="117188689" variantLength="3" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5502731" SubmissionDate="2022-12-17" DateLastUpdated="2023-01-07" DateCreated="2023-01-07">
        <ClinVarSubmissionID localKey="NM_000492.3:c.1210-12T[5]|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002818248" DateUpdated="2023-01-07" DateCreated="2023-01-07" Type="SCV" Version="1" SubmitterName="Al Jalila Childrens Genomics Center, Al Jalila Childrens Speciality Hospital" OrgID="507199" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.1210-12T[5]</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12445851</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7556397" SubmissionDate="2023-09-28" DateLastUpdated="2023-10-07" DateCreated="2023-10-07">
        <ClinVarSubmissionID localKey="nvtapin_pin_19625" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004037539" DateUpdated="2023-10-07" DateCreated="2023-10-07" Type="SCV" Version="1" SubmitterName="GenomeConnect - Invitae Patient Insights Network" OrgID="508034" OrganizationCategory="patient registry" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Comment>Variant classified as Pathogenic and reported on 07-26-2017 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">30</Age>
              <Age Type="maximum" age_unit="years">39</Age>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Diagnostic</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <Description>Gene Panel Sequencing</Description>
              <MethodType>phenotyping only</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2017-07-26" integerValue="500031">Invitae</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet DateLastEvaluated="2019-03-09" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002099" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002793" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002721" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002719" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.117188688_117188689del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0010674" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0403814" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0238339" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13855872</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7901509" SubmissionDate="2023-12-29" DateLastUpdated="2024-01-26" DateCreated="2024-01-26">
        <ClinVarSubmissionID localKey="nvtapin_pin_14427" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004228523" DateUpdated="2024-01-26" DateCreated="2024-01-26" Type="SCV" Version="1" SubmitterName="GenomeConnect - Invitae Patient Insights Network" OrgID="508034" OrganizationCategory="patient registry" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Comment>Variant interpreted as Pathogenic and reported on 07-07-2016 by Lab LabCorp. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">50</Age>
              <Age Type="maximum" age_unit="years">59</Age>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <Description>Gene Panel Sequencing</Description>
              <MethodType>phenotyping only</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2016-07-07" integerValue="29669">Laboratory Corporation of America Holdings</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet DateLastEvaluated="2019-01-13" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000545" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002242" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001732" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.117188688_117188689del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1865433" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14120880</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8987369" SubmissionDate="2024-03-26" DateLastUpdated="2024-04-06" DateCreated="2024-04-06">
        <ClinVarSubmissionID localKey="NM_000492.4:c.1210-7_1210-6del|OMIM:219700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004807015" DateUpdated="2024-04-06" DateCreated="2024-04-06" Type="SCV" Version="1" SubmitterName="Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center" OrgID="508075" OrganizationCategory="other" OrgAbbreviation="CGM_KFSHRC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-26">
          <ReviewStatus>flagged submission</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.4:c.1210-7_1210-6del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="219700" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment DataSource="ClinGen" Type="FlaggedComment">Notes: None</Comment>
        <Comment DataSource="ClinGen" Type="FlaggedComment">Reason: Outlier claim with insufficient supporting evidence</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB14340316</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8994679" SubmissionDate="2024-04-05" DateLastUpdated="2024-04-15" DateCreated="2024-04-15">
        <ClinVarSubmissionID localKey="4096643_NM_000492.4:c.1210-7_1210-6del|OMIM:219700" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004812068" DateUpdated="2024-04-15" DateCreated="2024-04-15" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0006280" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000413" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.4:c.1210-7_1210-6del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="219700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14360025</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="27810" TraitType="Disease" MappingType="Name" MappingValue="VAS DEFERENS, CONGENITAL BILATERAL ABSENCE OF" MappingRef="Preferred">
        <MedGen CUI="C0403814" Name="Congenital bilateral aplasia of vas deferens from CFTR mutation" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8987369" TraitType="Disease" MappingType="XRef" MappingValue="219700" MappingRef="OMIM">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7556397" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002099" MappingRef="HP">
        <MedGen CUI="C0004096" Name="Asthma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="367423" TraitType="Disease" MappingType="Name" MappingValue="not specified" MappingRef="Preferred">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="88865" TraitType="Disease" MappingType="Name" MappingValue="BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1, MODIFIER OF" MappingRef="Alternate">
        <MedGen CUI="C4017631" Name="Bronchiectasis with or without elevated sweat chloride 1, modifier of" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4924016" TraitType="Disease" MappingType="XRef" MappingValue="167800" MappingRef="OMIM">
        <MedGen CUI="C0238339" Name="Hereditary pancreatitis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5502731" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7556397" TraitType="Disease" MappingType="XRef" MappingValue="C0010674" MappingRef="MedGen">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="645090" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3112850" TraitType="Disease" MappingType="XRef" MappingValue="C0010674" MappingRef="MedGen">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2307212" TraitType="Disease" MappingType="Name" MappingValue="CFTR-related disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="CFTR-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1732917" TraitType="Disease" MappingType="XRef" MappingValue="219700" MappingRef="OMIM">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901509" TraitType="Disease" MappingType="XRef" MappingValue="C1865433" MappingRef="MedGen">
        <MedGen CUI="C1865433" Name="Congenital bilateral absence of vas deferens" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8994679" TraitType="Disease" MappingType="XRef" MappingValue="219700" MappingRef="OMIM">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7556397" TraitType="Disease" MappingType="XRef" MappingValue="C0238339" MappingRef="MedGen">
        <MedGen CUI="C0238339" Name="Hereditary pancreatitis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7556397" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002719" MappingRef="HP">
        <MedGen CUI="C0239998" Name="Recurrent infections" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3877961" TraitType="Disease" MappingType="Name" MappingValue="not specified" MappingRef="Preferred">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1354337" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="643010" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901509" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001732" MappingRef="HP">
        <MedGen CUI="C4025751" Name="Abnormality of the pancreas" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901509" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002242" MappingRef="HP">
        <MedGen CUI="C4316788" Name="Abnormal intestine morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7556397" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002721" MappingRef="HP">
        <MedGen CUI="C0021051" Name="Immunodeficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8994679" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000413" MappingRef="HP">
        <MedGen CUI="C0266597" Name="Atresia of the external auditory canal" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901509" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000545" MappingRef="HP">
        <MedGen CUI="C0027092" Name="Myopia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2310536" TraitType="Disease" MappingType="Name" MappingValue="Inborn genetic diseases" MappingRef="Preferred">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2354254" TraitType="Disease" MappingType="XRef" MappingValue="219700" MappingRef="OMIM">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7556397" TraitType="Disease" MappingType="XRef" MappingValue="C0403814" MappingRef="MedGen">
        <MedGen CUI="C0403814" Name="Congenital bilateral aplasia of vas deferens from CFTR mutation" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3563150" TraitType="Disease" MappingType="XRef" MappingValue="277180" MappingRef="OMIM">
        <MedGen CUI="C0403814" Name="Congenital bilateral aplasia of vas deferens from CFTR mutation" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2307212" TraitType="Disease" MappingType="Name" MappingValue="cystic fibrosis" MappingRef="Preferred">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8994679" TraitType="Finding" MappingType="XRef" MappingValue="HP:0006280" MappingRef="HP">
        <MedGen CUI="C0149521" Name="Chronic pancreatitis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7556397" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002793" MappingRef="HP">
        <MedGen CUI="C1837388" Name="Abnormal pattern of respiration" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4016164" TraitType="Disease" MappingType="XRef" MappingValue="CN235283" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2670962" TraitType="Disease" MappingType="Name" MappingValue="Congenital bilateral aplasia of vas deferens from CFTR mutation" MappingRef="Preferred">
        <MedGen CUI="C0403814" Name="Congenital bilateral aplasia of vas deferens from CFTR mutation" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3799850" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011962" MappingRef="HP">
        <MedGen CUI="C4023106" Name="Obstructive azoospermia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="780029" TraitType="Disease" MappingType="Name" MappingValue="CFTR-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="CFTR-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3224948" TraitType="Disease" MappingType="XRef" MappingValue="C0010674" MappingRef="MedGen">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

